Joshua T. Brumm, See Remarks at Dyne Therapeutics, Inc. (DYN), sold 652,460 shares at $13.15 ($8.4M) on 2023-06-08, disclosed to the SEC on 2023-06-12.
Open-market sale of $8.4M DYN by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,800 | $0 | 0.0% |
| 2 | $13.15 | 46,811 | $616K | 7.3% |
| 3 | $13.15 | 46,811 | $616K | 7.3% |
| 4 | $13.47 | 14,189 | $191K | 2.3% |
| 5 | $13.47 | 14,189 | $191K | 2.3% |
| 6 | $13.34 | 76,582 |
| $1.0M |
| 12.2% |
| 7 | $13.34 | 76,582 | $1.0M | 12.2% |
| 8 | $12.61 | 187,748 | $2.4M | 28.2% |
| 9 | $12.61 | 187,748 | $2.4M | 28.2% |
| Total | $12.86 avg | 652,460 | $8.4M | 100% |
| Filing → |
| DYN | SELL | 2024-03-12 | $22.2M | — | Filing → |
| DYN | SELL | 2024-03-11 | $470K | — | Filing → |
| DYN | SELL | 2024-03-01 | $5.1M | — | Filing → |